Ailesel Alopesi ve Otoimmun Poliglanduler Sendrom Tip 3

Öz

Dermatoloji polikliniklerinde sıkça görülen alopesi areatanın genetik yatkınlık ve çevresel tetikleyici bir faktör ile ortaya çıkan organ spesifi k otoimmun bir hastalık olduğu ve sıklıkla diğer otoimmun hastalıklarla ilişkili olabildiği bilinmektedir. Alopesinin diğer otoimmun hastalıklarla birlikteliğinde otoimmun poliglanduler sendromlar tanımlanmaktadır. Otoimmun poliglanduler sendromlar günümüzde OPS tip 1, 2, 3, 4 olarak 4 ana tipe ayrılmakta olup, alopesi her tipte bulunabilmekle beraber en sık OPS tip 3’te görülmektedir. OPS tip 3 tanısı için otoimmun tiroid hastalığına ilaveten Addison hastalığı ve/veya hipoparatiroidizm dışında bir otoimmun hastalığının mevcudiyeti gerekmektedir. 2001 yılında Beterle OPS tip 3’ü 4 subgruba (tip 3A, 3B, 3C, 3D) ayırmış olup otoimmun tiroid hastalığına ilaveten alopesinin bulunması OPS tip 3C olarak sınıfl andırılmıştır.Burada alopesi areata tanısıyla kliniğimize başvurmuş 6 yaşında erkek hasta ve 5 yaşındayken alopesi universalis tanısı almış ağabeyi zaman içinde poliglandüler tutulum geliştirmeleri nedeniyle, alopesi areataya eşlik edebilecek otoimmun hastalıklar ve genetik incelemeler vurgulanmak istenmiştir.

Anahtar Kelimeler

• Alopesi areata, otoimmun poliglanduler sendromlar

FAMILIAL ALOPECIA AND AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE 3

Öz

Alopecia areata, which is frequently seen in dermatology policlinics, is known to be an organ specifi c autoimmune disease appearing with a genetic tendency and environmental triggering factors and is often associated with other organ specifi c autoimmune diseases. Autoimmune polyglandular syndromes are defi ned for the association of alopecia with other autoimmune diseases. Autoimmune polyglandular syndromes (APS) are divided into 4 major types as type 1, 2, 3, and 4. Alopecia appears in all types, especially in type 3 of APS. For the diagnosis of APS type 3, besides the presence of autoimmune thyroid disease, another autoimmune disease except Addison’s disease or hypoparathyroidism is required. In 2001, Betterle subdivides APS type 3 into four subgroups (Type 3A, 3B, 3C, and 3D) and coincidence of autoimmune thyroid disease with alopecia is classifi ed as type 3C.Here, 6-year-old male patient with the diagnosis of alopecia areata and his brother diagnosed as alopecia universalis when he was 5-year-old eventually had polyglandular involvement are presented to emphasize associated autoimmune diseases and genetic studies

Anahtar Kelimeler

• Alopecia areata, autoimmune polyglandular syndromes

Kaynakça

1. Wasserman D , Guzman-sanchez DA , Scott K , McMichael A: Alopecia areata. International Journal of Dermatology 2007 ;46 :121-131.
2. Hawit F, Silverberg N.B : Alopecia areata in children . Cutis . 2008;82:104 -110.
3. Kos L , Conlon J : An update on alopecia areata. Current Opinion in Pediatrics. 2009;21 475-480.
4. Hordinsky M, Ericson M: Autoimmunity : alopecia areata. J Investig Dermatol Symp Proc 2004; 9:73-78.
5. Colombe B.W, Lou C.D , Price V.H: The genetic basis of alopesi areata: HLA associations with patchy alopecia areata versus alope- si totalis and alopecia universalis. J Investig Dermatol Symp Proc. 1999;4:216-219.
6. Betterle C , Zancbetta R: Update on autoimmune polyendocrine syndromes(APS). Acta Biomed 2003;74:9-33.
7. Aung K, Salmon M: Polyglandular autoimmune syndrome, type 3. http://emedicine.medscape.com/article/124398-overview.
8. Obermayer-Straub P , Manns M.P: Autoimmune polyglandular syndromes. Bailliere’s Clinical Gastroenterology. 1998;12:293- 315.

9. Majeroni BA, Patel P : Autoimmune polyglandular syndrome, type 2. Am Fam Physician 2007;75:667-670.
10. Amerio P , Tracanna M , De Remigis P , Betterle C , Vianale L , Marra M.E , Di Rollo D , Capizzi R , Feliciani C , Tulli A : Vitiligo associated with other autoimmune diseases: polyglandular auto- immune syndrome types 3B+C and 4. Clinical and Experimental Dermatology. 2006;31:746-749.
11. Klapproth J-MA , Yang VW: Celiac sprue. http://emedicine.meds- cape.com/article/171805-overview.
12. Zawahir S , Safta A , Fasano A : Pediatric celiac disease. Current Opinion in Pediatrics. 2009;21:655-660.
13. Thom S , Longo BM , Running A , Ashley J: A guide to successful diagnosis and treatment. The Journal for Nurse Practitioners. 2009: 244-252.
14. Evans KE , Malloy AR , Gorard DA . Changing patterns of coeliac serology requests. Alimentary pharmacology&therepeutics.2009;2 9:1137-1142.
15. Van den Driesshe A , Eenkhhoorn V , Van Gaal L , De Block C : Type 1 diabetes and autoimmune polyglandular syndrome: a clini- cal review. Neth J Med. 2009;67:376-387.
16. Glader B : Megaloblastic Anemias . Nelson Textbook of Pediatrics. Ed. Behrman RE , Kliegman RM , Jenson HB . 17. baskı . U.S.A ,Elsevier Science 2004;1611-1613.
17. Carmel R: Reassessment of the relative prevalences of antibodies to gastric parietal cell and to intrinsic factor in patients with perni- cious anemia. Clin Exp Immunol. 1992;89:74-77.
18. Suzuki C , Hirai Y , Terui K , Kohsaka A , Akagi T , Suda T . Slowly progressive type1 diabetes mellitus associated with vitili- go vulgaris , chronic thyroiditis , and pernicious anemia. Internal Medicine. 2004;43:1183-1185.
19. Shimomura H , Nakase Y , Furuta H , Nishi M , Nakao T , Hanabusa T , Sasaki H , Okamoto K , Furukawa F , Nanjo K : A rare case of autoimmune polyglandular syndrome type3. Diabetes Research and Clinical Practice . 2003;61:103-108 .
20. Ugur-Altun B , Arıkan E , Guldiken S , Kara M , Tugrul A : Autoimmune polyglandular syndrome type 3 in monozygotic twins: a case report . Acta Clinica Belgica . 2004;59:225-228.